Adicet bio to participate in a fireside chat at the 2025 jefferies global healthcare conference

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for autoimmune diseases and cancer, today announced that chen schor, president and chief executive officer, will participate in a fireside chat at the jefferies global healthcare conference being held from june 3-5, 2025 in new york. details of the event are as follows: date: wednesday, june 4, 2025 time: 4:20.
ACET Ratings Summary
ACET Quant Ranking